-
Challenges in the measurement of brain iron deposition in Parkinson’s disease in non-academic research settings.
-
Challenges with oral anti-parkinsonian medications and opportunities with continuous subcutaneous infusion (CSCI) of foslevodopa/foscarbidopa (LDP/CDP) for treatment of advanced Parkinson’s Disease (aPD)
-
Change in quality of Life, depression, and lived experiences of women with Parkinson’s disease after deep drain stimulation
-
Changes in artistic style and Parkinson’s Disease
-
Changes in word fluency tasks and cognitive function before and after the COVID-19 epidemic in patients with Parkinson’s disease:PD.
-
Characterisation of OFF-Time in Levodopa-Treated Parkinson’s Patients: A Post-hoc Analysis of an Exploratory Trial
-
Characterisation of the pharmacokinetic profile of L-DOPA in the common marmoset
-
Characteristics of cases in which stimulation was programmed for multiple targets in deep brain stimulation therapy for Parkinson’s disease.
-
Characteristics of Huntington disease in a north Indian cohort
-
Characteristics of Pain in Parkinson’s Disease with Arabic translation and validation of King’s Parkinson’s Disease Pain Scale
- « Previous Page
- 1
- …
- 30
- 31
- 32
- 33
- 34
- …
- 186
- Next Page »